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From gene manager to traffic cop
A 
protein that tweaks gene expres-
sion moonlights in the cytoplasm, 
Xu et al. show (1). The protein, 
which is part of a histone-modifying 
complex in the nucleus, regulates endosome 
traffi  cking in the cytoplasm and might 
infl   uence when cells crawl and when 
they stay put.
Histone lysine methyltransferase 
complexes affi  x methyl groups to lysines 
in the H3 and H4 histones. Depending on 
the circumstances, the additions can turn 
gene activity up or down (2). Researchers 
are learning that a growing number of other 
proteins—including the tumor-fi  ghter 
p53—also accrue methyl groups. “That’s 
a clue that methyltransferases might 
do something else,” says senior author 
Dzwokai “Zach” Ma. However, says Ma, 
the team was surprised that the something 
else entailed intracellular transport.
Xu et al. got their fi   rst inkling of 
this alternative function while performing 
a yeast two-hybrid screen to uncover 
rat brain cell proteins that latch onto a 
potassium channel. The experiment turned 
up mDpy-30, a component of several 
histone methyltransferase complexes (3). 
Whether mDpy-30 and the channel also 
interact in vivo—and why—is unknown. 
But the fi  nding spurred the team to further 
investigate mDpy-30.
The protein was prevalent not only 
in the nucleus, the researchers found, but 
also in the trans-Golgi network, suggesting 
a role in membrane traffi  cking. To clarify 
that role, the researchers tracked the 
protein CIMPR, which ushers newly 
made enzymes from the trans-Golgi 
network to the lysosomes. Some CIMPR 
normally shuttles between the plasma 
membrane and Golgi apparatus in early, 
recycling, and late endosomes. When 
the team trimmed mDpy-30 levels with 
RNAi, CIMPR amassed at protrusions 
that cells extend when beginning to crawl. 
However, depletion of mDpy-30 didn’t 
alter traffi  cking of two other proteins that 
ride in early and recycling endosomes, 
suggesting that mDpy-30’s job involves 
the late endosomes.
Further evidence that mDpy-30 
takes part in late endosome transport came 
when the team followed a labeled version 
of CIMPR from the cell surface to a site 
where late endosomes gather near the Golgi 
apparatus. Within 15 minutes, CIMPR had 
made the trip in about 80% of cells. When 
mDpy-30 levels were down, however, 
CIMPR reached this location in only one-
half to one-third as many cells within the 
same period. Instead, the protein detoured 
to the protrusions and built up there.
The team also took a closer look at 
what happens at the protrusions by testing for 
Rab GTPases that characterize specifi  c kinds 
of endosomes. The extensions 
teemed with Rab4 and Rab11, 
both of which mark recycling 
endosomes, but not with Rabs 
linked to other types of en-
dosomes. Together, the fi  nd-
ings suggest that disrupting 
mDpy-30 stalls transport to 
the Golgi apparatus in late 
endosomes, leading to a pile-
up of recycling endosomes 
near the membrane.
That leaves two big questions 
to answer. The fi   rst is how mDpy-30 
infl   uences intracellular transportation. One 
possibility is that it teams up with its histone-
methylating partners at the Golgi, forming 
complexes that modify traffi  c  regulating 
proteins. The team found that knocking 
down two of these partners, Ash2L and 
RbBP5, had the same effect on CIMPR 
distribution as depletion of mDpy-30. 
However, the researchers couldn’t fi  nd 
evidence that Ash2L and RbBP5 gather at 
the trans-Golgi network, so the complexes’ 
direct participation in traffi  cking remains 
in doubt. Another option, Ma says, is that 
both pools of mDpy-30—nuclear and 
Golgi—participate. The cytoplasmic pool 
might direct traffi  c, for example, while the 
nuclear pool manages expression of gene 
products involved in endosomal transport. 
If that’s the case, Ma says, researchers 
also need to explain how the two pools of 
mDpy-30 integrate their actions.
The second big mystery concerns 
the function of mDpy-30’s traffi  c  con-
trol. “We suspect that one 
physiological consequence 
of this event is to control 
adhesion and migration,” 
says Ma. Formation of 
cell protrusions is the fi  rst 
step toward migration 
and previous studies have 
implicated CIMPR, Rab4, 
and Rab11 in cell movement 
(4, 5). So mDpy-30 might 
regulate cell movement by 
adjusting the membrane levels or surface 
distribution of key migratory molecules.
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Dzwokai Ma (back row, 
second from left) and 
colleagues chanced on 
a new function for the 
protein mDpy-30, already 
known to be part of a 
complex that modiﬁ  es gene 
expression. These images 
show that mDpy-30 (red) 
coincides with TGN46 
(green), a marker of the 
trans-Golgi network.
“We suspect 
that one 
physiological 
consequence of 
this event is to 
control adhesion 
and migration.”
“Nuclear” protein keeps endosomes rolling.
FOCAL POINT   